InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Calamari Christopher J., Chief Executive Officer. Officer active across 1 companies, notably Abbott Laboratories. In total, 5 disclosures have been published. The latest transaction was disclosed on 1 July 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€59,003569 shares@ €103.69660.0000% mcap18.5% of flow
Common shares without par value
SEC:0001415889-22-007180:0·
€259,2482,368 shares@ €109.47980.0001% mcap81.5% of flow
Common shares without par value
SEC:0001415889-22-002187:0·
012,812 shares0
Common shares without par value
SEC:0001415889-22-001731:0·
03,764 shares0
Common shares without par value
SEC:0001415889-21-003509·
03,764 shares0
Common shares without par value
SEC:0001415889-21-003509:0·
5 of 5 declarations
About Calamari Christopher J.
Christopher J. Calamari is the CEO at Abbott Laboratories. He is responsible for the strategic and operational direction of the company. His role includes managing resources and making key decisions to ensure growth and profitability. Through his leadership, he guides the company towards achieving its long-term objectives.
